Cat. #156523
Anti-Ahi-1
Cat. #: 156523
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Abelson Helper Integration Site 1
Class: Monoclonal
Application: WB
Reactivity: Mouse
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: BC Cancer
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-Ahi-1
- Alternate name: AHI-1; JBTS3
- Research fields: Cancer;Cell biology;Neurobiology
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 120 kDa
- Reactivity: Mouse
- Host: Mouse
- Application: WB
- Description: Ahi-1 is involved in vesicle trafficking and required for brain development. Mutations are associated with Joubert syndrome-related disorders, and elevated expression levels are found in chronic myeloid leukemia and cutaneous T-cell lymphoma.
- Immunogen: Anti-C-mAhi-1 M5 antibody reacts with an epitope in the c-terminal region of mouse Ahi-1 protein. A recombinant mouse Ahi-1 GST fusion protein was used as immunogen.
- Immunogen uniprot id: AHI1_MOUSE
- Isotype: IgG1
Target Details
- Target: Abelson Helper Integration Site 1
- Molecular weight: 120 kDa
- Target background: Ahi-1 is involved in vesicle trafficking and required for brain development. Mutations are associated with Joubert syndrome-related disorders, and elevated expression levels are found in chronic myeloid leukemia and cutaneous T-cell lymphoma.
Applications
- Application: WB
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Shipping at 4° C
References
- Zhou et al. 2008. J Exp Med. 205(11):2657-71. PMID: 18936234.
